Aadi Bioscience Inc Stock, NASDAQ:AADI
17383 Sunset Boulevard, Suite A250, Los Angeles, California 90272
United States of America
Number of Employees: 39
Aadi Bioscience, Inc. operates as a clinical-stage biopharmaceutical company. It develops precision therapies for genetically-defined cancers patients with mTOR pathway driver alterations such as alterations in TSC1 or TSC2 genes. The company was founded by Neil Desai on November 2007 and is headquartered in Los Angeles, CA.